pfizer oral glp 1 discontinues GLP-1 receptor agonist danuglipron Pfizer Advances Oral GLP-1 Development

It also activates and deactivates genes

Standard semaglutide dosing for weight loss starts at 0.25 mg per week and escalates to 2.4 mg

Once activated, these microglia release neurotoxic substances that further damage neuronal synapses and disrupt the synthesis of vital neurotransmitters like acetylcholine, dopamine, and serotonin

ScienceDaily.com slapped this headline on it: The Guardian reported: Healthline.com reported: Using relative risk reduction figures almost always makes the benefit seem larger than it really is, and thereby misleads the general public

Mounjaro and Wegovy are similar

Non-abstinence outcomes in the coming RCTs should be the primary endpoints I think